SCHROEDER ROBERT C 4
4 · MyMD Pharmaceuticals, Inc. · Filed Apr 20, 2021
Insider Transaction Report
Form 4
SCHROEDER ROBERT C
Director
Transactions
- Exercise/Conversion
Common Stock
2021-04-16+43,930→ 43,930 total - Tax Payment
Common Stock
2021-04-16$4.94/sh−14,694$72,588→ 29,236 total - Exercise/Conversion
Restricted Stock Units
2021-04-16−43,930→ 0 total→ Common Stock (43,930 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the "Company").
- [F2]Represent 14,694 shares of RSUs withheld to pay the reporting person's tax withholding obligations incurred in connection with the vesting of 43,930 shares of RSUs on April 16, 2021.
- [F3]On September 11, 2020, the reporting person was granted 43,930 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control.